Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIACT
NCT07458880Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Mar 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amlodipine, valsartan and hydrochlorothiazide in intracerebral hemorrhage (ICH) and hypertension (HTN) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Hypertension Control at 1 month. Started Mar 2026; status: recruiting.
02
Drugs
amlodipinevalsartanhydrochlorothiazide
03
Conditions
intracerebral hemorrhage (ICH)hypertension (HTN)
Beyond the preview
Go deeper on NCT07458880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07458880.